文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急诊科肺保护性通气与有创机械通气患者的结局及费用

Lung-Protective Ventilation and Associated Outcomes and Costs Among Patients Receiving Invasive Mechanical Ventilation in the ED.
PubMed 文献 · Chest · 2020-09-20
一句话结论急诊科对接受有创机械通气的成人使用潮气量≤8 mL/kg预测体重与住院死亡几率降低相关(aOR 0.91)。

该回顾性分析基于2011-2017年8个急诊科的前瞻性登记数据,纳入4174例在急诊科接受有创机械通气的成人患者。肺保护性通气定义为潮气量≤8 mL/kg预测体重,2437例(58.4%)在急诊科接受了肺保护性通气。肺保护性通气与住院死亡几率降低(aOR 0.91;95%CI 0.84-0.96)及ARDS发生几率降低(aOR 0.87;95%CI 0.81-0.92)相关,并与更短的机械通气时间、更短的住院时间及更低的住院总费用相关。作者认为制定促进急诊科常规使用肺保护性通气的方案可能有价值。

要点

  • 在急诊科接受有创机械通气的成人中,58.4%(2437/4174)使用了潮气量≤8 mL/kg预测体重的肺保护性通气。
  • 急诊科肺保护性通气与住院死亡几率降低相关(aOR 0.91;95%CI 0.84-0.96)。
  • 急诊科肺保护性通气与ARDS发生几率降低相关(aOR 0.87;95%CI 0.81-0.92)。
  • 肺保护性通气组中位机械通气时间4天 vs 较高潮气量组5天(P<0.01),中位住院时间11天 vs 14天(P<0.001)。
  • 肺保护性通气组住院总费用Can$44,348 vs 较高潮气量组Can$52,484(US$34,153 vs US$40,418;P=0.03)。

适用人群与场景

  • 2011-2017年8个急诊科的前瞻性登记中连续纳入的成人患者(≥18岁),均在急诊科接受有创机械通气。

诊断标准与关键阈值

  • 肺保护性通气定义为使用潮气量≤8 mL/kg预测体重。

研究设计与关键结果

  • 研究类型:基于前瞻性登记数据的回顾性分析(2011-2017年,8个急诊科),纳入4174例在急诊科接受有创机械通气的成人患者。
  • 暴露与对照:急诊科使用肺保护性通气(潮气量≤8 mL/kg预测体重)2437例(58.4%)vs 使用较高潮气量者。
  • 主要终点:肺保护性通气与住院死亡几率降低相关(aOR 0.91;95%CI 0.84-0.96)。
  • 关键次要终点:ARDS发生几率降低(aOR 0.87;95%CI 0.81-0.92);中位机械通气时间4天 vs 5天(P<0.01);中位住院时间11天 vs 14天(P<0.001);住院总费用Can$44,348 vs Can$52,484(US$34,153 vs US$40,418;P=0.03)。

证据类型、等级与局限

  • 证据类型:基于前瞻性登记数据的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,制定促进急诊科常规使用肺保护性通气的方案可能有价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Invasive mechanical ventilation is often initiated in the ED, and mechanically ventilated patients may be kept in the ED for hours before ICU transfer. Although lung-protective ventilation is beneficial, particularly in ARDS, it remains uncertain how often lung-protective tidal volumes are used in the ED, and whether lung-protective ventilation in this setting impacts patient outcomes.

RESEARCH QUESTION: What is the association between the use of lung-protective ventilation in the ED and outcomes among invasively ventilated patients?

STUDY DESIGN AND METHODS: A retrospective analysis (2011-2017) of a prospective registry from eight EDs enrolling consecutive adult patients (≥ 18 years) who received invasive mechanical ventilation in the ED was performed. Lung-protective ventilation was defined by use of tidal volumes ≤ 8 mL/kg predicted body weight. The primary outcome was hospital mortality. Secondary outcomes included development of ARDS, hospital length of stay, and total hospital costs.

RESULTS: The study included 4,174 patients, of whom 2,437 (58.4%) received lung-protective ventilation in the ED. Use of lung-protective ventilation was associated with decreased odds of hospital death (adjusted OR [aOR], 0.91; 95% CI, 0.84-0.96) and development of ARDS (aOR, 0.87; 95% CI, 0.81-0.92). Patients who received lung-protective ventilation in the ED had shorter median duration of mechanical ventilation (4 vs 5 days; P < 0.01), shorter median hospital length of stay (11 vs 14 days; P < .001), and reduced total hospital costs (Can$44,348 vs Can$52,484 [US$34,153 vs US$40,418]; P = .03) compared with patients who received higher tidal volumes.

INTERPRETATION: Use of lung-protective ventilation in the ED was associated with important patient- and system-centered outcomes, including lower hospital mortality, decreased incidence of ARDS, lower hospital length of stay, and decreased total costs. Protocol development promoting the regular use of lung-protective ventilation in the ED may be of value.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Fernando SM, Fan E, Rochwerg B, et al. Lung-Protective Ventilation and Associated Outcomes and Costs Among Patients Receiving Invasive Mechanical Ventilation in the ED. Chest. 2020. PMID: 32966812. doi:10.1016/j.chest.2020.09.100

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。